Pain in multiple sclerosis

D. B. Clifford and J. L. Trotter

We reviewed 317 patients with multiple sclerosis (MS) and found that the incidence of clinically significant pain, excluding headache and paresthesia, was 28.8%. Successful treatment requires recognition of the pathophysiology of the pain syndromes encountered in MS. Antidepressant drugs have been of particular value in the treatment of chronic pain in these patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lifetime and actual prevalence of pain and headache in multiple sclerosis
Martinelli Boneschi et al.
Mult Scler 2008;14:514-521.
ABSTRACT  

The scope and nature of pain in persons with multiple sclerosis
Ehde et al.
Mult Scler 2006;12:629-638.
ABSTRACT  

Severity of chronic pain and its relationship to quality of life in multiple sclerosis
Kalia and OConnor
Mult Scler 2005;11:322-327.
ABSTRACT  

The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study
Solaro et al.
Neurology 2004;63:919-921.
ABSTRACT | FULL TEXT  

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
Svendsen et al.
BMJ 2004;329:253.
ABSTRACT | FULL TEXT  

Pain in Patients With Multiple Sclerosis: A Population-Based Study
Svendsen et al.
Arch Neurol 2003;60:1089-1094.
ABSTRACT | FULL TEXT  

A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis
Al-Smadi et al.
Clin Rehabil 2003;17:742-749.
ABSTRACT  

Trigeminal neuralgia--pathophysiology, diagnosis and current treatment
Nurmikko and Eldridge
Br J Anaesth 2001;87:117-132.
ABSTRACT | FULL TEXT  

Lamotrigine adjunctive therapy in painful phenomena in MS: Preliminary observations
Cianchetti et al.
Neurology 1999;53:433-433.
FULL TEXT  

Pharmacologic Management of Spinal Spasticity
Herman and D'Luzansky
Neurorehabil Neural Repair 1991;5:S15-S20.
ABSTRACT